Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes

OBJECTIVE: To determine variables associated with glycemic and body weight responses when adding exenatide to basal insulin–treated type 2 diabetes. RESEARCH DESIGN AND METHODS: Exploratory subgroup analyses based on baseline A1C, disease duration, and BMI of a 30-week study comparing exenatide twic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rosenstock, Julio, Shenouda, Sylvia K., Bergenstal, Richard M., Buse, John B., Glass, Leonard C., Heilmann, Cory R., Kwan, Anita Y.M., MacConell, Leigh A., Hoogwerf, Byron James
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2012
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3329851/
https://ncbi.nlm.nih.gov/pubmed/22432107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc11-1434
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires